STAT+: How digital therapeutics companies are improvising when insurance coverage isn’t guaranteed
STAT
JANUARY 18, 2024
Pear received Food and Drug Administration clearance for its app treating substance use disorders and insomnia but insurers mostly refused to cover the novel treatments. For years, the playbook for many companies that wanted to market digital therapeutics was stupid simple: Sell it like a prescription drug.
Let's personalize your content